You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IX-01

Showing 1 - 25 of 1,376
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Participants Trial in London (IX-01)

Completed
Has Results
  • Healthy Participants
  • IX-01
  • London, United Kingdom
    Hammersmith Medicines Research
Aug 5, 2020

Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia B

Active, not recruiting
  • Hemophilia B
  • AAV5-hFIX
  • Berlin, Germany
  • +5 more
Jan 17, 2023

Failed Back Surgery Syndrome Trial in Bardejov (Epiduroscopy treatment, Racz catheter epidural procedure, Caudal epidural block)

Completed
  • Failed Back Surgery Syndrome
  • Epiduroscopy treatment
  • +2 more
  • Bardejov, Slovakia
    EuroPainClinics
Dec 30, 2021

Premature Ejaculation Trial in Australia, United States (IX-01, Placebo)

Completed
Has Results
  • Premature Ejaculation
  • IX-01
  • Placebo
  • San Diego, California
  • +9 more
Aug 5, 2020

Premature Ejaculation Trial in United States (IX-01 400 mg, Placebo, IX-01 800 mg)

Completed
Has Results
  • Premature Ejaculation
  • IX-01 400 mg
  • +3 more
  • Mobile, Alabama
  • +28 more
Sep 13, 2019

Dermatitis, Atopic, Eczema Trial in Worldwide (CC-93538, Placebo)

Completed
  • Dermatitis, Atopic
  • Eczema
  • Birmingham, Alabama
  • +156 more
Dec 12, 2022

Hemophilia B Trial in United Kingdom, United States (Gene Transfer, scAAV2/8-LP1-hFIXco)

Active, not recruiting
  • Hemophilia B
  • Stanford, California
  • +7 more
Nov 17, 2022

Clear Cell Renal Cell Carcinoma Metastatic, TNBC - Triple-Negative Breast Cancer, Head Neck Cancer Trial (CA9hu-1)

Not yet recruiting
  • Clear Cell Renal Cell Carcinoma Metastatic
  • +4 more
  • (no location specified)
Jan 13, 2023

Hemophilia B Trial (BBM-H901)

Not yet recruiting
  • Hemophilia B
  • (no location specified)
Feb 6, 2023

CA-IX, p16, Proliferative Markers, and HPV in Diagnosing

Active, not recruiting
  • Atypical Endometrial Hyperplasia
  • +2 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Tucson, Arizona
  • +162 more
Oct 27, 2022

Hemophilia B Trial in Worldwide (FLT180a)

Terminated
Has Results
  • Hemophilia B
  • FLT180a
  • Memphis, Tennessee
  • +10 more
Nov 8, 2022

Triple Negative Breast Cancer Trial in Saint-Herblain (89Zr-TLX250 PET/CT)

Recruiting
  • Triple Negative Breast Cancer
  • 89Zr-TLX250 PET/CT
  • Saint-Herblain, France
    ICO René Gauducheau
Oct 18, 2021

Hemophilia Trial in Orange (Fitusiran, Clotting factor concentrates (CFC) or bypassing agents (BPA), Antithrombin concentrate

Recruiting
  • Hemophilia
  • Orange, California
    Center for Inherited Blood Disorders (CIBD)-Site Number:8400012
Feb 2, 2023

Clostridium Difficile Infection Trial in Worldwide (Clostridium difficile vaccine, Placebo)

Completed
  • Clostridium Difficile Infection
  • Clostridium difficile vaccine
  • Placebo
  • Athens, Alabama
  • +425 more
Oct 4, 2022

Rheumatoid Arthritis Trial in Worldwide (Sarilumab, Adalimumab, Placebo (for sarilumab))

Completed
Has Results
  • Rheumatoid Arthritis
  • Covina, California
  • +85 more
Mar 15, 2022

Hemophilia B, Blood Coagulation Disorders, Inherited, Blood Coagulation Disorder Trial in Worldwide

Recruiting
  • Hemophilia B
  • +3 more
    • Phoenix, Arizona
    • +55 more
    Dec 6, 2021

    Glycogen Storage Disease VI, GLYCOGEN STORAGE DISEASE IXa1, GLYCOGEN STORAGE DISEASE IXa2 Trial in Durham (No intervention)

    Recruiting
    • Glycogen Storage Disease VI
    • +4 more
    • No intervention
    • Durham, North Carolina
      Duke University
    Jul 27, 2022

    Prostate Cancer Trial in Worldwide (enzalutamide, abiraterone acetate, prednisone)

    Recruiting
    • Prostate Cancer
    • Anchorage, Alaska
    • +126 more
    Aug 23, 2022

    Hemophilia B Without Inhibitor Trial (Low dose KL001, Middle dose KL001, High dose KL001)

    Not yet recruiting
    • Hemophilia B Without Inhibitor
    • Low dose KL001
    • +2 more
    • (no location specified)
    Nov 5, 2023

    Hemophilia B Without Inhibitor Trial (Low dose KL001, Middle dose KL001, High dose KL001)

    Not yet recruiting
    • Hemophilia B Without Inhibitor
    • Low dose KL001
    • +2 more
    • (no location specified)
    Nov 5, 2023

    Porto-Venous Radiomics in Pancreatic Cancer

    Recruiting
    • Pancreatic Cancer
    • Non-Interventional
    • London, United Kingdom
      The Royal Marsden NHS Foundation Trust
    Jan 17, 2023

    Healthy Trial in Adelaide (TR-01-XRR (1), TR-01-XRR (2), TR-01-XRR (3))

    Not yet recruiting
    • Healthy
    • TR-01-XRR (1)
    • +6 more
    • Adelaide, South Australia, Australia
      CMAX Clinical Research
    Feb 3, 2023

    Hypoxia and Metabolism in Clear Cell Renal Cell Carcinoma

    Recruiting
    • Clear Cell Renal Cell Carcinoma
    • No intervention was required for patients or control group in this study
    • Jinan, China
      The First Affiliated Hospital of Shandong First Medical Universi
    Mar 7, 2022

    Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments

    Completed
    • Hemophilia A
    • +2 more
    • Vitamin K Antagonist - Drug
    • Brest, France
    • +5 more
    Apr 6, 2023

    Tibial Shaft Fractures Trial in Sohag (interlocking intramedullary tibial nail)

    Recruiting
    • Tibial Shaft Fractures
    • interlocking intramedullary tibial nail
    • Sohag, Egypt
      Sohag University hospitals
    Nov 19, 2023